Bullboard Post History

by CUR2004

Order by:

DGCRF	RE: RE: GPRO acquires CUR but "Perhaps i am missing the point and Tempress cannot be ran together with... February 21, 2012
DGCRF	RE: now is the real lift off... From the Gen-Probe website “From a commercial perspective, this is the... February 15, 2012
DGCRF	FDA approves PROGENSA® PCA3 assay FDA approves PROGENSA® PCA3 assay First Urine-Based Molecular... February 15, 2012
DGCRF	CONFERENCE REPORT CONFERENCE REPORT Urine-Based Markers May Pinpoint Prostate Cancer Patients... February 6, 2012
DGCRF	RE: At least $200K saved a year... She leave on december.http://ca.linkedin.com/pub/paule-de-blois/4/73b/188 February 5, 2012
DGCRF	Study shows an investigational urine test can pred Study shows an investigational urine test can predict high-risk prostate... February 2, 2012
DGCRF	FAIR MARKET VALUATION PRICE FAIR MARKET VALUATION PRICE Based on available data as of Jan 31, 2012, we... January 31, 2012
DGCRF	Molecular Detection of Prostate Cancer with PROGEN Sky news videohttp://medical.prostatecanceronline.info/blog-news/molecular... January 31, 2012
DGCRF	Quebec’s Five Most Interesting Biotech Stocks Quebec&CloseCurlyQuote;s Five Most Interesting Biotech StocksJanuary 21... January 24, 2012
DGCRF	Study published in the February 1 issue of Cancer Test Leads To More Accurate Diagnoses, Fewer False-positive Results Posted on... January 23, 2012
DGCRF	RE: DCF: Cash Burn Rate Hi, Could you explain what is the difference between these two type of... January 12, 2012
DGCRF	RE: RE: RE: Deutsche Bank initiates GPRO today I think the 16% royalties are based on the sales of Gen-Probe to the... December 19, 2011
DGCRF	Better sales forces in Canada Gamma-Dynacare Medical Laboratories Acquires Warnex Medical Laboratories... December 13, 2011
DGCRF	RE: Most-Read Pathology Articles in 2011 Most-Read Pathology Articles in 2011Here is the link http://www... December 9, 2011
DGCRF	Most-Read Pathology Articles in 2011 http://www.medscape.com/viewarticle/754746 December 9, 2011
DGCRF	New study to guide initial biopsy decisions Beyond the Abstract - Clinical Evaluation of the PCA3 Assay in Guiding... November 18, 2011
DGCRF	RE: More on PSA; WaPo Is it a good or bad news? Do you think Gen-Probe do change on his FDA... October 7, 2011
DGCRF	Royalties on Previstage From the webcast presentation of Diagnocure at the Rodman & Renshaw... September 13, 2011
DGCRF	RE: RE: NEW PCA3 WEB SITE From Diagnocure website:Canadian laboratoriesThe following laboratories offer... September 7, 2011
DGCRF	No more biopsy in Australia The Future has arrived today: The world’s very first commercially-available... August 28, 2011

Become a member today, It's free!

Bullboard Post History

by CUR2004

RE: RE: GPRO acquires CUR but

RE: now is the real lift off...

FDA approves PROGENSA® PCA3 assay

CONFERENCE REPORT

RE: At least $200K saved a year...

Study shows an investigational urine test can pred

FAIR MARKET VALUATION PRICE

Molecular Detection of Prostate Cancer with PROGEN

Quebec’s Five Most Interesting Biotech Stocks

Study published in the February 1 issue of Cancer

RE: DCF: Cash Burn Rate

RE: RE: RE: Deutsche Bank initiates GPRO today

Better sales forces in Canada

RE: Most-Read Pathology Articles in 2011

Most-Read Pathology Articles in 2011

New study to guide initial biopsy decisions

RE: More on PSA; WaPo

Royalties on Previstage

RE: RE: NEW PCA3 WEB SITE

No more biopsy in Australia

Featured Company

Western Metallica Resources Corp. V.WMS

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by CUR2004

Featured Company